等待开盘 04-03 09:30:00 美东时间
+0.340
+0.72%
今日重点评级关注:杰富瑞:上调BioAge Labs评级至"买入",目标价从9美元升至62美元;RBC Capital:维持COMPASS Pathways Plc Sponsored ADR"跑赢大市"评级,目标价从21美元升至22美元
02-19 16:21
After a long mega-cap tech-dominated leadership, the market has entered 2026 on less stable ground. SP 500 (ARCA: SPY) is breakeven for the year, while the Magnificent 7 stocks average 7.3% negative return.
02-17 01:47
JPMorgan believes AI won't disrupt software companies as much as feared. They recommend investing in quality names.
02-13 20:26
今日重点评级关注:HC Wainwright & Co.:维持NovoCure"买入"评级,目标价从39美元升至47美元;HC Wainwright & Co.:维持Agios制药"买入"评级,目标价从62美元升至65美元
02-13 15:30
Needham analyst Mayank Tandon maintains Q2 Holdings (NYSE:QTWO) with a Buy and lowers the price target from $90 to $70.
02-12 21:09
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Q2 Holdings业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **营收表现:** - Q4总营收2.082亿美元,同比增长14%,环比增长3% - 全年营收7.948亿美元,同比增长14%,为2021年以来最高年度增长率 - 订阅收入Q4同比增长16%,全年同比增长17%,占总营收82% - 非订阅收入全年增长2%,主要来自并购相关核心转换的专业服务收入增加 **盈利能力:** - Q4毛利率58.6%,同比提升120个基点(从57.4%),环比提升70个基点 - 全年毛利率58%,同比提升200个基点(从56%) - Q4调
02-12 12:15
华盛资讯2月12日讯,Q2 Holdings, Inc.公布2025财年Q4业绩,公司Q4营收2.08亿美元,同比增长13.8%,归母净利润0.20亿美元,同比增长12365.2%。
02-12 06:12
Q2 Holdings shares are trading lower after the company reported mixed Q4 financ...
02-12 05:23
The Q4 earnings report for Q2 Holdings (NYSE:QTWO) was released on Wednesday, F...
02-12 05:20